Home › Funds › UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME › LLY

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME position in LLY

ELI LILLY & CO · Health Care

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME reported holding 8,375,693 shares of LLY (ELI LILLY & CO) in its Q3 2026 13F filing — a position valued at US$9.69B, representing 1.47% of its reported portfolio and ranking #10 among its reported holdings. UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME has disclosed LLY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)8.38M sh
Reported value held$9.69B
Portfolio Weight1.47%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME's LLY position evolved

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME first disclosed a stake in LLY in Q3 2023 at 4,372,782 shares (US$2.35B). The position peaked in Q3 2026 at 8,375,693 shares, worth US$9.69B. Across 13 filings, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME increased the stake 10 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 8,375,693 shares valued at US$9.69B — an increase of 1,166,308 shares quarter over quarter.. Notable position changes include a 29% increase in Q2 2024 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.37M $2.35B New
Q4 2023 4.50M $2.62B Add
Q1 2024 4.62M $3.59B Add
Q2 2024 5.96M $5.39B Add
Q3 2024 6.12M $5.42B Add
Q4 2024 7.08M $5.47B Add
Q1 2025 6.78M $5.60B Reduce
Q2 2025 7.87M $6.14B Add
Q3 2025 6.43M $4.91B Reduce
Q4 2025 6.50M $6.98B Add
Q1 2026 7.07M $6.50B Add
Q2 2026 7.21M $8.65B Add
Q3 2026 8.38M $9.69B Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LLY and 13F data

LLY (ELI LILLY & CO) is a Health Care company. 33 other funds we track also report a position in LLY — the largest reported positions include LILLY ENDOWMENT INC (US$104.21B), Vanguard Group (US$88.09B), VANGUARD CAPITAL MANAGEMENT LLC (US$62.39B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LLY

All LLY fund holders →

FAQ

How long has UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME held LLY?

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME has disclosed LLY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME's current position in LLY?

As of Q3 2026, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME holds 8.38M shares of LLY (ELI LILLY & CO), valued at $9.69B, representing 1.47% of its reported portfolio and ranking #10.

Has UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME been buying or selling LLY?

In the latest 13F filing (Q3 2026), UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME increased its position in LLY. The position peaked in Q3 2026 at 8.38M shares.

Which other funds hold LLY?

Other major institutional holders of LLY include LILLY ENDOWMENT INC, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.